Navigation Links
EasyFlo™ Uroflowmetry System

ProductsEasyFlo™ Uroflowmetry System
Company SRS Medical
Item EasyFlo™ Uroflowmetry System
Features 
  • A Full Range of Clinical Measures
  • Urine flow pattern (graphically)
  • Total voided volume
  • Total void time
  • Urine flow time
  • Average urine flow
  • Maximum (peak) flow
  • Onset-to-peak flow time
  • Liverpool Nomogram (Normative comparisons)
  • Quick screening tool for voiding dysfunction
  • One-touch operation
  • Minimal investment, rapid return on investment
Description A uroflow study remains the mainstay in a urologic workup. The EasyFlo was designed to meet physician and patient needs for an accurate, easy-to-use in-office uroflow system. EasyFlo automatically starts the test with the onset of urine flow and automatically ends when a period of 30 seconds elapses with no urine flow. There is no need to have personnel present to switch off the device. Each patients result is then placed into the Liverpool nomogram for comparison against the normal population and all results are printed.
Info SRS Medical
Customer Service: (800) 345-5642
Web site: http://www.srsmedical.com/

Related medicine products :

1. Urocap-II™ Uroflowmetry System
2. Silicone Oil Cannula System - 20 Gauge
3. Silicone Oil Cannula System - 19 Gauge
4. SuperVu Galilean System
5. KOWA nonmyd 7 / VK-2 Digital Imaging System
6. KOWA nonmyd a-D / VK-2 Digital Imaging System
7. Refraction System RT-2100
8. Odyssey Phacoemulsification System
9. SIStem Phacoemulsification System
10. Precisionist Phacoemulsification System
11. Photon Laser Phacoemulsification System
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products:
(Date:1/8/2009)...Call/ -- Allscripts-Misys Healthcare,Solutions, I.... (Allscripts or,the Company), today announced it...ended November 30, 2008. , (Logo: http://w...O-b ) , The Company,s results for the three...esults from legacy Allscripts for the period of Oc...
(Date:1/8/2009)...wire/ -- The Pew Charitable Trusts announced today...cal and food safety programs, in its Health & ...erly deputy staff director and general counsel of ...ks, brings nearly 25 years of experience in enviro..., "We are excited to be joined by such an experie...
(Date:1/8/2009)...ristine Siu and Jason Brown, Ph.D. Promoted to Vic...STAMFORD, Conn., Jan. 8 Thomas, Mc...al firm that invests in life science and medical t... of three members of its investment team. Kathy T... and Jason Brown have been promoted to Vice Presid...
(Date:1/8/2009)...wswire/ -- A proposal by the State of Indiana to c...ome has prompted the 125,000-member American Legio...inter conference January 10-12, 2009, in order to ...ous opposition to the proposal. , , The Legion,...ct and in-kind support to the home, is among the f...
Breaking Medicine News(10 mins):Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2
...glaucoma awareness among Mexican-Americans, who ha... Casa Grande Valley Dispatch reports. Mexican-Am... with a family history of glaucoma all face a high...t of Hispanics have primary open-angle glaucoma, t...
...l Sociology, author Alison Howell traces the psych...es , noting that both advocates and resisters of t...he impaired psyches of the suspects. As the high...he Guantanamo Bay terrorist detention center has c...
...ional Journal of Obstetrics and Gynaecology shows ... and placental abruption during the subsequent pr...section. Placental praevia is defined as the imp...ar the internal opening of the cervix. Placenta ab...
...lives to work- related cancers and heart attacks c...bor laws state that they no longer need to prove ...ation due the dead workers family. The changes ...s of cancer that will be presumed to have been wor...
Other Medicine News:Health News:Study Examines the Pathologization of Guantanamo Suicides 2Health News:Placental Problems in Women Linked With Caesarean Section 2Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 2Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 3
(Date:1/8/2009)...-- If you are taking prescription medicine,and fo...he people taking,prescription medicine don,t take... forget, are busy with other priorities, or make a...n called the Achilles heel of modern,healthcare. ..."Drugs don,t,work in people who don,t take them."...
(Date:1/7/2009)...e-USNewswire/ -- Scientists have identified mutati...lapse in children with acute lymphoblastic leukemi...ther research is needed to determine how changes i...ukemia relapse, the findings are likely to provide...he risk of treatment failure. By using a molecular...
(Date:1/7/2009)...iantan Puhua Hospital Stem Cells Center ( http://w...sing stem cells to effectively treat neurological ...enced additions to its medical and research staff ... capabilities for growing numbers of incoming inte... the distinguished Dr. Jiang Ping, who was named C...
(Date:1/6/2009).../ -- In recent controlled studies conducted by Dr....sts found that the patented ingredient in Glyc,n G...ingredient to increase levels of nitric oxide (NO)...rate (NOx) in human subjects. , , Nitric oxide ...lood flow to the skeletal muscles. This is signif...
Breaking Medicine Technology:Good Medicine: Smarter Smartphones for People With Chronic Disease 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Veterinarians Pediatricians and Postal Workers Team Up to Reduce Incidence of Dog Bites 19526 1Veterinarians Pediatricians and Postal Workers Team Up to Reduce Incidence of Dog Bites 19526 2Escalon 28R 29 Reports Third Quarter Fiscal 2008 Results 5455 1Escalon 28R 29 Reports Third Quarter Fiscal 2008 Results 5455 2Escalon 28R 29 Reports Third Quarter Fiscal 2008 Results 5455 3Escalon 28R 29 Reports Third Quarter Fiscal 2008 Results 5455 4Escalon 28R 29 Reports Third Quarter Fiscal 2008 Results 5455 5Escalon 28R 29 Reports Third Quarter Fiscal 2008 Results 5455 6Escalon 28R 29 Reports Third Quarter Fiscal 2008 Results 5455 7Escalon 28R 29 Reports Third Quarter Fiscal 2008 Results 5455 8Bioheart Inc Announces Financial Results for First Quarter 2008 5451 1Bioheart Inc Announces Financial Results for First Quarter 2008 5451 2Bioheart Inc Announces Financial Results for First Quarter 2008 5451 3Bioheart Inc Announces Financial Results for First Quarter 2008 5451 4Bioheart Inc Announces Financial Results for First Quarter 2008 5451 5Bioheart Inc Announces Financial Results for First Quarter 2008 5451 6Bioheart Inc Announces Financial Results for First Quarter 2008 5451 7New Guidelines Issued for Implanted Heart Devices 19520 1New Guidelines Issued for Implanted Heart Devices 19520 2
...om Phase III Intergroupe Francophone du Myelome (I..., July 02, 2007 /PRNewswire-FirstCall/ --,Millenni...ata were,presented on the comparative Phase III cl... newly diagnosed multiple myeloma (MM),patients. A...tion,(SCT), the VELCADE based therapy produced a h...
...um, 2 July, 2007 -- Ablynx today announced positiv...f its lead,development programme, ALX-0081, an ant...;first-in-class´ therapeutic,Nanobody® t...duce the risk of thrombosis in patients with acute... volunteers is designed to assess,safety, tolerabi...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6Ablynx Announces Interim Results of First Nanobody Phase I Study of,ALX-0081 (ANTI-VWF) 2